LEXARIA BIOSCIENCE CORP. Proceeds from Long-Term Debt Issued
LEXARIA BIOSCIENCE CORP. (LEXX) reported Proceeds from Long-Term Debt Issued of $30.67 thousand for the 12-month period ending 2020-08-31, per its 10-K filed 2020-10-15.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2020-10-15
- LEXARIA BIOSCIENCE CORP. proceeds from issuance of long-term debt for the quarter ending 2020-08-31 was $1.91K.
- LEXARIA BIOSCIENCE CORP. proceeds from issuance of long-term debt for fiscal 2020 was $30.67K.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month |
|---|---|---|---|
| 2020-08-31 | $1.91K derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-15 | $30.67K 10-K · filed 2020-10-15 | |
| 2020-05-31 | $28.76K 10-Q · filed 2020-06-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |